Improved Diagnosis of the Transition to JAK2V617F Homozygosity: The Key Feature for Predicting the Evolution of Myeloproliferative Neoplasms

PLoS ONE - United States
doi 10.1371/journal.pone.0086401
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Routine Blood Examinations Combined With Morphological Analysis for the Diagnosis of Myelodysplastic/Myeloproliferative Neoplasms

Oncology Letters
Cancer ResearchOncology
2016English

Progressive Diagnosis of Chronic Myeloproliferative Neoplasms: A Case Study

American Society for Clinical Laboratory Science
2019English

New Classification for Myeloproliferative Neoplasms

Cancer Discovery
Oncology
2018English

Characteristics of the Four Subtypes of Myelodysplastic/Myeloproliferative Neoplasms

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Histological Evaluation of Myeloproliferative Neoplasms

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

Advances in Understanding the Pathogenesis of Familial Myeloproliferative Neoplasms

British Journal of Haematology
Hematology
2017English

Major Changes to the 2017 Revision of the World Health Organization Classification of Myeloproliferative Neoplasms

The Korean Journal of Medicine
2018English

Sex Differences in the JAK2V617F Allele Burden in Chronic Myeloproliferative Disorders

Haematologica
Hematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy